Loading Video...
NTHRYS
Arrow

Immunology / Immuno Technology Training Programs - 100 Programs | NTHRYS

NTHRYS >> Services >> Academic Services >> Training Programs >> Immunology / Immuno Technology Training Programs - 100 Programs | NTHRYS

Immunology / Immuno Technology Training Programs

Immunology / Immuno Technology Training Programs at NTHRYS in Hyderabad, Telangana, India provide comprehensive academic, research, industrial and applicative training tracks covering modern immunology, immune analytics, therapeutics development, quality systems and translational applications.

Training Areas under Immunology / Immuno Technology at NTHRYS

  1. Antibody Engineering
  2. Monoclonal Antibody Production
  3. Polyclonal Antibody Production
  4. Hybridoma Technology
  5. Recombinant Antibody Expression
  6. Antibody Humanization
  7. Immunoassay Development ELISA
  8. CLIA & Chemiluminescent Assays
  9. Lateral Flow Assay Design
  10. Multiplex Immunoassays
  11. Neutralization Assays
  12. Flow Cytometry (Basics)
  13. Advanced Flow Cytometry Panels
  14. Cell Sorting (FACS)
  15. Imaging Flow Cytometry
  16. Cytometry Data Analysis
  17. T-Cell Immunology
  18. B-Cell Immunology
  19. NK Cell Biology
  20. Dendritic Cell Technology
  21. Macrophage Functional Assays
  22. Cytokine Profiling
  23. TCR/BCR Sequencing
  24. Immune Repertoire Analysis
  25. Immunogenomics & NGS
  26. Single-Cell Immunology
  27. Cancer Immunology
  28. Cancer Immunotherapy
  29. CAR-T Cell Technology
  30. Checkpoint Inhibitors
  31. Tumor Microenvironment Assays
  32. Vaccine Development
  33. Adjuvants & Formulations
  34. Antigen Design & Expression
  35. Vaccine Analytics
  36. Animal Models in Immunology
  37. Autoimmune Disease Research
  38. Transplant Immunology
  39. Infectious Disease Immunology
  40. Allergy & Hypersensitivity
  41. Mucosal Immunity
  42. Clinical Immunology Lab Practices
  43. Immunodiagnostics in Clinical Labs
  44. QC/QA in Immunoassays
  45. Regulatory Compliance (GMP/GLP)
  46. Biostatistics for Immunology
  47. Bioinformatics for Immune Data
  48. AI/ML in Immunology
  49. Network Biology of Immunity
  50. Systems Immunology
  51. Quantitative Immunology Modeling
  52. Western Blot & IFA
  53. Immunoprecipitation & Co-IP
  54. ChIP/ChIP-seq in Immunology
  55. Immunofluorescence Microscopy
  56. Confocal Imaging in Immunology
  57. Epitope Mapping
  58. Antibody Affinity Maturation
  59. Antibody-Drug Conjugates
  60. Bispecific & Multispecific Antibodies
  61. Nanobody Technology
  62. Complement System Assays
  63. Innate Immunity Techniques
  64. Pattern Recognition Receptors
  65. Inflammasome Biology
  66. Cellular Signaling in Immunity
  67. Host-Pathogen Interactions
  68. Viral Immunology
  69. Bacterial Immunology
  70. Fungal & Parasitic Immunology
  71. TB & Granuloma Immunity
  72. Microbiome & Immunity
  73. Gut Immunology
  74. Respiratory Immunology
  75. Dermatological Immunology
  76. Neuroimmunology
  77. Reproductive Immunology
  78. Pediatric Immunology
  79. Geriatric Immunology & Immunosenescence
  80. Immunometabolism
  81. Stem Cells in Immunology
  82. CRISPR Gene Editing for Immune Cells
  83. RNAi & Gene Silencing
  84. Cell Therapy Manufacturing Basics
  85. Bioprocessing for Immunobiologics
  86. Scale-Up & Tech Transfer
  87. Biophysical Characterization of Antibodies
  88. SPR & Binding Kinetics
  89. Glycosylation Analysis
  90. Stability & Stress Studies
  91. Impurity & Host Cell Protein Assays
  92. Sterility & Endotoxin Testing
  93. Mycoplasma & Adventitious Agent Testing
  94. Environmental Monitoring for Immune Labs
  95. Cold Chain & Biologics Logistics
  96. Risk Management in Immuno Projects
  97. GLP Documentation & SOPs
  98. Clinical Trial Design in Immunology
  99. Pharmacokinetics & PD for Biologics
  100. Immunogenicity Assessment
  101. Biomarker Discovery & Validation
  102. High-Content Screening in Immunity
  103. CRISPR Screens for Immune Targets
  104. Phenotypic Assays for Immuno-Oncology
  105. Primary Immune Cell Isolation
  106. Organoid & Co-culture Models
  107. Patient-Derived Xenografts (PDX)
  108. HLA Typing & Matching
  109. Minor Antigens & GVHD
  110. Tolerance Induction Strategies
  111. Immunosuppressive Therapies


PDF